tirzepatide another name FDA approves new version of diabetes drug Mounjaro to be sold for weight loss Tirzepatide vs. Semaglutide: Which Weight
Description
GLP-1 weight loss drugs have been so popular that drug makers could not keep up with public demand
The data of 4,887 participants treated with tirzepatide and those of the 2,328 control participants were analysed
Retatrutide is not currently licensed for use in the United Kingdom
Detailed instructions can be found on the back of this patient information
Those with pre-existing eye conditions should inform their healthcare provider, though routine eye screening is not specifically required for patients without diabetes or known eye disease
